Freemont Management’s Intuitive Surgical ISRG Stock Holding History

Freemont Management’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,500	Closed	-$2.07M	–	76
2026 Q1	$2.07M	Sell	4,500 -500	-10%	-$253K	0.31%	88
2025 Q4	$2.83M	Buy	+5,000	New	+$2.66M	0.49%	58

Other funds holding ISRG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Freemont Management's ISRG Position: Q2 2026 in Review

Freemont Management sold out of Intuitive Surgical (ISRG) in Q2 2026, closing a stake of 4,500 shares — an estimated $2.07M sold.

Freemont Management first reported a position in ISRG in Q4 2025 and held it in 2 quarters. The position peaked at $2.83M in Q4 2025. 2,258 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

Freemont Management reported no remaining Intuitive Surgical position as of Q2 2026 after selling out during the quarter.
Freemont Management sold 4,500 Intuitive Surgical shares in Q2 2026, an estimated $2.07M.
Freemont Management first reported a position in Intuitive Surgical in Q4 2025 and held it in 2 quarters.
Freemont Management's Intuitive Surgical position peaked at $2.83M in Q4 2025.
2,258 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Freemont Management's 13F filing for Q2 2026, filed 11 Aug 2026.